CHRYSALIS BIOTHERAPEUTICS, INC.
GALVESTON, United States · Founded 2016 · $10.1M raised
- Headquarters
- GALVESTON, Texas
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2G
- Website
- chrysbio.com
- Total Funding
- $10.1M
- Last Round
- $10.1M Grant
- Rounds
- 1
About
Chrysalis BioTherapeutics is a clinical-stage biopharmaceutical company developing regenerative peptide drugs based on TP508 (Rusalatide acetate), a synthetic peptide that activates endothelial and stem cells to stimulate tissue repair. Lead programs target acute respiratory distress syndrome (ARDS) and radiation-induced injuries in collaboration with BARDA and NIAID. The company has raised over $30M primarily through non-dilutive government funding.
Summary
CHRYSALIS BIOTHERAPEUTICS, INC. is a Biotech company based in GALVESTON, United States, founded in 2016. It has raised $10.1M in total across 1 round. Investors include Biomedical Advanced Research and Development Authority (BARDA).
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/chrysalis-biotherapeutics-inc"><img src="https://indexed.vc/api/badge/company/chrysalis-biotherapeutics-inc" alt="CHRYSALIS BIOTHERAPEUTICS, INC. on Indexed.vc" width="260" height="76" /></a>